azathioprine has been researched along with Thrombotic Microangiopathies in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Thrombotic Microangiopathies: Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SF | 1 |
Wang, H | 1 |
Huang, YM | 1 |
Li, ZY | 1 |
Wang, SX | 1 |
Yu, F | 1 |
Zhao, MH | 1 |
Chen, M | 1 |
Shirai, T | 1 |
Ishii, T | 1 |
Watanabe, R | 1 |
Tajima, Y | 1 |
Fujii, H | 1 |
Takasawa, N | 1 |
Sato, H | 1 |
Harigae, H | 1 |
2 other studies available for azathioprine and Thrombotic Microangiopathies
Article | Year |
---|---|
Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Topics: ADAM Proteins; ADAMTS13 Protein; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Ant | 2015 |
Thrombotic microangiopathy presenting with a considerable accumulation of ascites: a case report.
Topics: Ascites; Azathioprine; Blood Transfusion; Cyclophosphamide; Humans; Immunosuppressive Agents; Kidney | 2011 |